Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

IKK Alpha + IKK beta Polyclonal Antibody, Cy5.5 Conjugated

Product Specifications

Background

IKK Alpha/IKK beta is a member of the IKK complex which is composed of IKK alpha, IKK beta, IKK gamma and IKAP. Phosphorylation of I-Kappa-B on a serine residue by the IKK complex frees NF-kB from I-Kappa-B and marks it for degradation via ubiquination. IKK beta has been shown to activate NF-kB and phosphorylate IKB alpha and beta. Phosphorylation of 2 sites at the activation loop of IKK beta is essential for activation of IKK by TNF and IL1. Once activated, IKK beta autophosphorylates which in turn decreases IKK activity and prevents prolonged activation of the inflammatory response. Additionally, IKK beta activity can also be regulated by MEKK1.

Synonyms

IKK-Alpha; I kappa A kinase 2; I kappa A kinase Alpha; IkBKA; IKK 1; IKKA; IKK Alpha; IKK A; IKK Alpha; IKK1; IKKA; IKK-_; I kappa B kinase 2; I kappa B kinase beta; IkBKB; IKK 2; IKK_; IKK _; IKK B; IKK beta; IKK2; IKKB; Inhibitor of kappa light chain gene enhancer in B cells; Inhibitor of kappa light polypeptide gene enhancer in B cells; Inhibitor of kappa light polypeptide gene enhancer in B cells kinase beta; Inhibitor of nuclear factor kappa B kinase beta subunit; Inhibitor of nuclear factor kappa B kinase subunit beta; MGC131801; NFKBIKB; Nuclear factor NF kappa B inhibitor kinase beta; Nuclear factor of kappa light chain gene enhancer in B cells inhibitor.

Cellular Locus

Cytoplasm, Nucleus, Cell membrane

Host

Rabbit

Cross Reactivity

Human, Mouse

Immunogen

151-250/756

Target

IKK Alpha + IKK beta

Clonality

Polyclonal

Isotype

IgG

Conjugation

Cy5.5

Source

KLH conjugated synthetic peptide derived from human IKK Alpha/IKK beta

Applications

WB, IF (IHC-P), IF (IHC-F), IF (ICC)

Purification

Purified by Protein A.

Excitation Emission

675nm/694nm

Concentration

1µg/µl

Dilution

WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)

Buffer

Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Predicted Cross Reactivity

Rat, Dog, Cow, Pig, Horse, Chicken

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Cyanoacetic Acid for Synthesis
056445-01 500 g

Cyanoacetic Acid for Synthesis

Ask
View Details
Cyanoacetic Acid for Synthesis
056445-02 1 kg

Cyanoacetic Acid for Synthesis

Ask
View Details
CD86 (T-lymphocyte Activation Antigen CD86, Activation B7-2 Antigen, Early T-cell Costimulatory Molecule 1, ETC-1, B7, B7.2, B70, B7-2, Cd28l2, TS/A-2) (APC) discontinued
137800 100 µg

CD86 (T-lymphocyte Activation Antigen CD86, Activation B7-2 Antigen, Early T-cell Costimulatory Molecule 1, ETC-1, B7, B7.2, B70, B7-2, Cd28l2, TS/A-2) (APC) discontinued

Ask
View Details
Human CCDC112 Pre-designed siRNA Set A
SI002291A 1 Each

Human CCDC112 Pre-designed siRNA Set A

Ask
View Details
Lithium nitrate, anhydrous, 99.995%
GX9077-250g 250 g

Lithium nitrate, anhydrous, 99.995%

Ask
View Details
GENLISA Equine Bone Morphogenetic Protein 2 (BMP2) ELISA
KLV0219 1x 96 Well

GENLISA Equine Bone Morphogenetic Protein 2 (BMP2) ELISA

Ask
View Details